These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 18725591

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study.
    Iuchi T, Kuwabara K, Matsumoto M, Kawasaki K, Hasegawa Y, Sakaida T.
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1158-62. PubMed ID: 25511789
    [Abstract] [Full Text] [Related]

  • 5. The risk of hypotension and seizures in patients receiving prophylactic anti-epileptic drugs for supratentorial craniotomy.
    Höhne J, Schebesch KM, Ott C, Brawanski A, Lange M.
    J Neurosurg Sci; 2018 Aug; 62(4):418-422. PubMed ID: 27854111
    [Abstract] [Full Text] [Related]

  • 6. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C, Ishihara K, Nagayama T, Serikawa T, Sasa M.
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [Abstract] [Full Text] [Related]

  • 7. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ, Arif H, Buchsbaum R, Weintraub D, Lee J, Chang JT, Resor SR, Bazil CW.
    Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
    [Abstract] [Full Text] [Related]

  • 8. Tolerability and efficacy of oral loading of levetiracetam.
    Koubeissi MZ, Amina S, Pita I, Bergey GK, Werz MA.
    Neurology; 2008 May 27; 70(22 Pt 2):2166-70. PubMed ID: 18505995
    [Abstract] [Full Text] [Related]

  • 9. A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis.
    Inaba K, Menaker J, Branco BC, Gooch J, Okoye OT, Herrold J, Scalea TM, Dubose J, Demetriades D.
    J Trauma Acute Care Surg; 2013 Mar 27; 74(3):766-71; discussion 771-3. PubMed ID: 23425733
    [Abstract] [Full Text] [Related]

  • 10. Utility of levetiracetam in patients with subarachnoid hemorrhage.
    Shah D, Husain AM.
    Seizure; 2009 Dec 27; 18(10):676-9. PubMed ID: 19864168
    [Abstract] [Full Text] [Related]

  • 11. Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage.
    Murphy-Human T, Welch E, Zipfel G, Diringer MN, Dhar R.
    World Neurosurg; 2011 Feb 27; 75(2):269-74. PubMed ID: 21492729
    [Abstract] [Full Text] [Related]

  • 12. Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.
    Bähr O, Hermisson M, Rona S, Rieger J, Nussbaum S, Körtvelyessy P, Franz K, Tatagiba M, Seifert V, Weller M, Steinbach JP.
    Acta Neurochir (Wien); 2012 Feb 27; 154(2):229-35; discussion 235. PubMed ID: 21909835
    [Abstract] [Full Text] [Related]

  • 13. A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury.
    Pieracci FM, Moore EE, Beauchamp K, Tebockhorst S, Barnett CC, Bensard DD, Burlew CC, Biffl WL, Stoval RT, Johnson JL.
    J Trauma Acute Care Surg; 2012 Jan 27; 72(1):276-81. PubMed ID: 22310136
    [Abstract] [Full Text] [Related]

  • 14. Intravenous levetiracetam for epileptic seizure emergencies in older people.
    Beyenburg S, Reuber M, Maraite N.
    Gerontology; 2009 Jan 27; 55(1):27-31. PubMed ID: 18953167
    [Abstract] [Full Text] [Related]

  • 15. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
    Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, Chang S, Lamborn KR, McDermott MW.
    J Neurooncol; 2009 Jul 27; 93(3):349-54. PubMed ID: 19169651
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS, Benatar M.
    Epilepsia; 2007 Jun 27; 48(6):1123-7. PubMed ID: 17430408
    [Abstract] [Full Text] [Related]

  • 17. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group.
    Epilepsia; 2009 Mar 27; 50(3):406-14. PubMed ID: 19317886
    [Abstract] [Full Text] [Related]

  • 18. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.
    Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA.
    Neurocrit Care; 2010 Apr 27; 12(2):165-72. PubMed ID: 19898966
    [Abstract] [Full Text] [Related]

  • 19. Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam.
    Kruer RM, Harris LH, Goodwin H, Kornbluth J, Thomas KP, Slater LA, Haut ER.
    J Crit Care; 2013 Oct 27; 28(5):883.e9-13. PubMed ID: 23566730
    [Abstract] [Full Text] [Related]

  • 20. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
    Ramsay E, Faught E, Krumholz A, Naritoku D, Privitera M, Schwarzman L, Mao L, Wiegand F, Hulihan J, CAPSS-272 Study Group.
    Epilepsia; 2010 Oct 27; 51(10):1970-7. PubMed ID: 20633037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.